Resources

What is the life expectancy for a child born in the U.S in 2007…Full Story

The Lancet has published a meta-analysis of the six large-scale randomized clinical trials of aspirin in the primary prevention of cardiovascular disease among over 95,000 apparently healthy men and women worldwide.

A genetic link between gum disease (periodontitis) and heart disease has been discovered by German scientists. This could be an important finding for those with diabetes because of the increased risk of heart disease to gum disease The association between periodontitis and coronary heart disease (CHD) has been known for …

The diabetes drug pioglitazone (Actos) significantly improved psoriasis control when added to oral acitretin (Soriatane), data from a small clinical trial demonstrated. This could be an important finding due to the fact that many people with diabetes also have psoriasis.

Intravenous clot-busting therapy with tissue plasminogen activator (tPA) should be administered up to 4.5 hours from stroke onset in eligible patients, according to a science advisory from the American Heart Association/American Stroke Association.

Far fewer Americans are engaging in healthy lifestyles than there were just two decades ago, researchers say. So it is not hard to see why a diabetes epidemic is at our doorstep.

Primary care physicians who counsel their African American patients about obesity should remain sensitive to the perceptions of their patients, according to a new report.

With more than 120,000 patients having a bariatric surgery procedure, we now have a database that can help in determining which patients would benefit from the different forms of bariatric surgery.

A couple of weeks ago we had a new product blurb about Cycloset(tm), an old drug with a new indication for diabetes. Many of you wrote to ask me for information on how the medication works and where the idea came from. I had our current PharmD candidate, Robert Fredenrich, …

Treating Type 2 diabetes patients with a cholesterol-lowering drug called fenofibrate cuts the risk of a first diabetes-related limb amputation by 36%, according to a new study published in The Lancet.